tyrosine has been researched along with ST Elevated Myocardial Infarction in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Li, R; Tang, X; Zhang, T | 1 |
| Ahmann, M; Al-Sadoon, I; Konyi, A; Kun, S; Verzár, Z; Wittmann, I | 1 |
| Chen, Q; Geng, G; Han, W; Hao, Y; Hao, Z; Jia, K; Liu, H; Liu, L; Liu, Y; Wang, D; Zhou, Y | 1 |
| Fabris, E; Giannitsis, E; Hamm, C; Kennedy, MW; Kilic, S; Kolkman, E; Ottervanger, JP; Schellings, DAAM; Ten Berg, JM; van Houwelingen, KG; Van't Hof, AWJ | 1 |
| Gao, D; Hu, S; Li, H; Li, M; Wang, H; Zhang, H; Zhu, J | 1 |
| Davakhar, S; Hiremath, S; Krishna, K; Lakade, S | 1 |
| Aparci, M; Balta, S; Celik, T; Demir, M; Demirkol, S; Iyisoy, A; Kaya, MG; Kilic, S; Ozturk, C; Unlu, M; Yildirim, OA | 1 |
| Li, WM; Liu, Y; Ni, ZH; Wang, HS; Wang, LF; Xia, K; Xu, L; Yang, XC; Zhang, DP | 1 |
| Dai, SP; Geng, T; Luo, Y; Song, ZY; Xu, ZS; Zhang, JG | 1 |
| Borklu, EB; Cinier, G; Eren, M; Hayiroglu, MI; Kaya, A; Keskin, M; Tatlisu, MA; Uzman, O | 1 |
| Cao, Z; Gao, L; Zhang, H | 1 |
| Bao, D; Chen, Y; Cong, H; Ding, S; Han, Y; Jia, S; Jing, Q; Li, J; Li, L; Li, Y; Liang, Z; Liu, B; Liu, H; Wang, H; Zhao, X | 1 |
7 trial(s) available for tyrosine and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
Comparison of intracoronary versus intravenous tirofiban in acute ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
Topics: Anterior Wall Myocardial Infarction; Arrhythmias, Cardiac; Hemorrhage; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Tirofiban; Treatment Outcome; Tyrosine | 2022 |
Short-term efficacy and safety of three different antiplatelet regimens in diabetic patients treated with primary percutaneous coronary intervention: a randomised study.
Topics: Adenosine; Aged; Aspirin; Clopidogrel; Diabetic Cardiomyopathies; Double-Blind Method; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Patient Safety; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Ticagrelor; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine | 2017 |
Long-term mortality and prehospital tirofiban treatment in patients with ST elevation myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Emergency Medical Services; Europe; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Survival Rate; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Young Adult | 2017 |
[The effect and safety of tirofiban on acute ST segment elevation myocardial infarction patients receiving no early reperfusion therapy].
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Safety; Secondary Prevention; ST Elevation Myocardial Infarction; Tirofiban; Treatment Outcome; Tyrosine | 2016 |
Aspiration thrombectomy and intracoronary tirofiban in ST-segment elevation myocardial infarction : Combination treatment for patients undergoing primary percutaneous coronary intervention.
Topics: China; Combined Modality Therapy; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Prevalence; Risk Factors; ST Elevation Myocardial Infarction; Survival Rate; Thrombectomy; Tirofiban; Treatment Outcome; Tyrosine | 2016 |
Efficacy and Safety of Thrombectomy Combined with Intracoronary Administration of Tirofiban in ST-segment Elevation Myocardial Infarction (STEMI).
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Combined Modality Therapy; Coronary Angiography; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Thrombectomy; Thrombosis; Tirofiban; Tyrosine | 2016 |
Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in acute myocardial infarction versus heparin and GPI plus heparin trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Cardiac Catheterization; China; Emergencies; Female; Hemorrhage; Hirudins; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Peptide Fragments; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Radial Artery; Recombinant Proteins; Risk Assessment; Risk Factors; ST Elevation Myocardial Infarction; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Warfarin; Young Adult | 2017 |
5 other study(ies) available for tyrosine and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
Assessment of serum phenylalanine and tyrosine isomers in patients with ST-segment elevation vs non-ST-segment elevation myocardial infarction.
Topics: Acute Coronary Syndrome; Aged; Female; Humans; Isomerism; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Phenylalanine; Prospective Studies; ST Elevation Myocardial Infarction; Tyrosine | 2021 |
Effect of intra-coronary administration of tirofiban through aspiration catheter on patients over 60 years with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Topics: Aged; Aged, 80 and over; Angiography; Angioplasty, Balloon, Coronary; Catheters; Drug Administration Routes; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Perfusion Imaging; Myocardium; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2018 |
Acute Myocardial Infarction in Nephrotic Syndrome.
Topics: Adult; Anterior Wall Myocardial Infarction; Coronary Angiography; Coronary Vessels; Fibrinolytic Agents; Humans; Hypertension; Injections, Intra-Arterial; Male; Nephrotic Syndrome; Nitroglycerin; ST Elevation Myocardial Infarction; Thrombectomy; Tirofiban; Treatment Outcome; Tyrosine; Vasodilator Agents | 2015 |
Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Topics: Adult; Age Factors; Chi-Square Distribution; Coronary Circulation; Female; Humans; Logistic Models; Lymphocyte Count; Male; Mean Platelet Volume; Middle Aged; No-Reflow Phenomenon; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Count; Retrospective Studies; Risk Factors; Sex Factors; ST Elevation Myocardial Infarction; Time Factors; Time-to-Treatment; Tirofiban; Treatment Outcome; Tyrosine | 2016 |
The association of the coronary thrombus burden with all-cause mortality and major cardiac events in ST-segment elevation myocardial infarction patients treated with tirofiban.
Topics: Aged; Cause of Death; Coronary Thrombosis; Female; Hemorrhage; Hospital Mortality; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors; ST Elevation Myocardial Infarction; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2016 |